Anzeige
Erschienen in:
01.10.2005 | Article
Interactive influences of peroxisome proliferator-activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat
Erschienen in: Diabetologia | Ausgabe 10/2005
Einloggen, um Zugang zu erhaltenAbstract
Aims/hypothesis
We sought to elucidate whether excess glucocorticoids and increased dietary lipids act synergistically to impair glucose tolerance and, if so, whether activation of peroxisome proliferator-activated receptor α (PPARα) has an adverse or beneficial effect on glucose tolerance.
Methods
Dexamethasone (100 μg kg−1 body weight day−1; 5 days) was administered to insulin-resistant rats fed a high-saturated-fat (HF) diet for 4weeks. The PPARα agonist WY14643 was administered (50 mg kg−1 body weight intraperitoneally) 24 h before sampling. Glucose-stimulated insulin secretion (GSIS) was assessed in vivo after an acute glucose bolus injection, and in vitro using step-up and step-down islet perifusions.
Results
Although neither PPARα activation nor dexamethasone alone affected fasting glycaemia in the HF group, dexamethasone in combination with PPARα activation elicited marked postabsorptive hyperglycaemia. Dexamethasone treatment of HF rats had little effect on GSIS after an acute glucose challenge in vivo, but induced glucose intolerance. PPARα activation augmented GSIS in dexamethasone-treated HF rats in vivo, restoring glucose tolerance. Contrasting with data obtained in vivo, greatly enhanced peak rates of GSIS were observed ex vivo in perifusions of islets from dexamethasone-treated HF rats compared with those from untreated HF rats, an effect attenuated by antecedent PPARα activation.
Conclusions/interpretation
The study demonstrates that glucocorticoid excess precipitates the development of glucose intolerance in rats maintained on a high-saturated-fat diet. It does this by interrupting the negative feedback loop between insulin sensitivity and secretion in vivo, such that further enhancement of compensatory insulin secretion is not possible. PPARα activation restores the coupling between insulin secretion and action.